Shaun C Williams
Affiliation: Woolcock Institute of Medical Research
- The effect of modafinil following acute CPAP withdrawal: a preliminary studyShaun C Williams
Sleep and Circadian Research Group, Woolcock Institute of Medical Research, Sydney, Australia
Sleep Breath 12:359-64. 2008..04) compared to placebo. These data do not support the use of modafinil for the maintenance of daytime functioning in patients with OSA who are acutely withdrawn from CPAP...
- Modafinil effects during acute continuous positive airway pressure withdrawal: a randomized crossover double-blind placebo-controlled trialShaun C Williams
Sleep and Circadian Research Group NHMRC Centre for Sleep Medicine, Woolcock Institute, University of Sydney and Royal Prince Alfred Hospital, Sydney, Australia
Am J Respir Crit Care Med 181:825-31. 2010..However, interruption of CPAP therapy is common and is associated with a decline in daytime function...
- Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trialJulia L Chapman
The NHMRC Centre for Integrated Research and Understanding of Sleep CIRUS, The University of Sydney, Sydney, New South Wales, Australia
Thorax 69:274-9. 2014..Modafinil is a wake-promoting drug licensed to treat residual sleepiness in CPAP-treated OSA. We hypothesised that modafinil may effectively treat sleepiness in untreated mild to moderate OSA...
- Modafinil Increases Awake EEG Activation and Improves Performance in Obstructive Sleep Apnea during Continuous Positive Airway Pressure WithdrawalDavid Wang
Sleep and Circadian Group, Woolcock Institute of Medical Research, University of Sydney, Australia
Sleep 38:1297-303. 2015....